Ability to image cerebral metabolic rate of oxygen (CMRO 2 ) is essential for studying the fundamental role of oxidative metabolism in brain function and disease. We have demonstrated recently that three-dimensional (3D) CMRO 2 images can be obtained in the rat brain during a 2-min 17 O 2 inhalation using the 17 O MR spectroscopic imaging (MRSI) approach at high field. The feasibility for establishing a completely noninvasive approach for imaging CMRO 2 has also been demonstrated. In this study, we further explored the feasibility of 17 O MRSI approach for performing repeated CMRO 2 measurements within a short period of time and evaluated the reproducibility of the repeated measurements. Subsequently, we applied the 17 O MRSI approach to measure CMRO 2 and cerebral blood flow (CBF) values at two brain temperatures in the a-chloralose anesthetized rat brain at 9.4 T. Finally, we tested the validity of simplified model for noninvasively determining CMRO 2 in normothermic and hypothermic rat brain. The results show (i) an excellent reproducibility among repeated measurements of 3D CMRO 2 images under the same physiologic condition; (ii) a 44% decrease of CMRO 2 across the rat brain at mild hypothermic (321C) condition as compared with normothermic (371C) condition; and (iii) a close correlation between CMRO 2 and CBF within a relatively wide physiologic range. This study demonstrates the capability of 17 O MRSI approach for noninvasively imaging CMRO 2 and its changes caused by physiologic perturbation. This approach, thus, should provide a promising neuroimaging modality for studying oxidative metabolism and bioenergetics associated with brain functions and diseases.
Introduction
The cerebral metabolic rate of oxygen utilization (CMRO 2 ) is tightly associated with brain physiology and pathology (Siesjo, 1978) . Determination of CMRO 2 is important for understanding the essential role of oxidative metabolism in brain function and brain diseases. The most straightforward nuclear magnetic resonance (NMR) method for directly measuring CMRO 2 is the use of 17 O NMR technique to determine the dynamic change of metabolic H 2 17 O, which is formed in mitochondria through oxygen metabolism of inhaled 17 O 2 (Arai et al, 1990; Fiat and Kang, 1992; Mateescu and Fercu, 1994; Mateescu et al, 1991; Pekar et al, 1991; Zhu et al, 2002) . However, the major challenges of 17 O NMR technique are its low intrinsic NMR sensitivity because of the low gyromagnetic ratio of 17 O spins and relatively small change in the metabolic H 2 17 O concentration generated during an 17 O 2 inhalation. Recently, we have demonstrated a substantial sensitivity gain for detecting 17 O NMR signal at high/ultrahigh magnetic field (Zhu et al, 2001 ). This crucial sensitivity improvement at higher field can be attributed to the field-independent relaxivity of the 17 O spins in H 2 17 O, which leads to a significant sensitivity gain according to a quadratic power relation with the magnetic field strength (Zhu et al, 2001 (Zhu et al, , 2005 ). This gain makes it possible to use the in vivo 17 O MR spectroscopic imaging (MRSI) approach for obtaining a three-dimensional (3D) CMRO 2 image in a rat brain at 9.4 T during a 2-mins 17 O 2 inhalation (Chen et al, 2004; Zhu et al, 2002 Zhu et al, , 2005 . Moreover, the feasibility for establishing a completely noninvasive 17 O MRSI approach for imaging CMRO 2 in vivo and the validity of the simplified approach for quantifying CMRO 2 have been demonstrated in the rat brain anesthetized with a-chloralose (Zhang et al, 2004) .
One potential and important merit of the 17 O MRSI approach is its ability allowing repeated CMRO 2 measurements during the same experimental session. Because in the brain tissue, the metabolic H 2 17 O generated during a brief 17 O 2 inhalation can be washed out quickly and reach a new steadystate concentration within approximately 10 mins after the ceasing of 17 O 2 inhalation (Zhu et al, 2002) . This characteristic allows subsequent measurements of CMRO 2 , which are particularly valuable for studies aiming at CMRO 2 changes induced by physiologic or pathologic perturbations. However, to fully realize this advantage, the reproducibility of the repeated CMRO 2 measurements has to be assessed and validated. Therefore, the first part of this paper was to evaluate the reproducibility of in vivo 17 O MRSI approach for repeated 3D CMRO 2 measurements in the rat brain under the same physiologic condition.
It is well documented that the basal CMRO 2 is sensitive to the brain temperature (see (Erecinska et al, 2003; Siesjo, 1978) and the references cited therein). However, most studies reported in the literature were based on the global CMRO 2 measurements of entire brain using the Kety-Schmidt method (Kety and Schmidt, 1948a, b) , which was lack of spatial information regarding regional CMRO 2 variation inside the brain. In the second part of this study, we investigated the feasibility of using 3D
17 O MRSI at 9.4 T for imaging and quantifying absolute CMRO 2 values in the rat brain at normal brain temperature (371C) (i.e., normothermia) and mild hypothermia (321C) conditions. We also compared CMRO 2 calculation results based on two different models: a completed model requiring both invasive and noninvasive measurements (Zhu et al, 2002) , and a simplified model requiring only one noninvasive measurement of dynamic concentration change of metabolic H 2 17 O in the brain tissue during a 2-min 17 O 2 inhalation (Zhang et al, 2004) . This comparison was performed under both normothermia and hypothermia conditions. Finally, the measured CMRO 2 results in this study were correlated with the cerebral blood flow (CBF) results, which were experimentally determined via bolus injection of H 2 17 O tracer into the brain through the internal carotid artery (Zhu et al, 2001) . These data were obtained from a-chloralose anesthetized rat brains under a wide range of physiologic conditions including both normothermia and hypothermia.
Materials and methods
All NMR experiments were conducted on a 9.4 T horizontal animal magnet (Magnex Scientific, Abingdon, UK) interfaced to a Varian INOVA console (Palo Alto, CA, USA). A multinuclear surface-coil probe consisting of a butterfly-shape 1 H coil (400 MHz) and an oval-shape 17 O coil (B1 cm Â 2 cm, 54.25 MHz) was used for acquiring anatomic 1 H images and in vivo 17 O MRSI data, respectively. Scout images were acquired using a turbo fast low-angle shot (TurboFLASH) imaging sequence with the following acquisition parameters: repetition time (TR) = 8 msecs; echo time (TE) = 4 msecs, field of view (FOV) = 3 cm Â 3 cm, and image matrix size = 128 Â 128. The spatial localization of 17 O MRSI was achieved by using the 3D Fourier series window approach (Hendrich et al, 1994; Zhu et al, 2001) . All animal surgical procedures and experimental protocols were approved by the Institutional Animal Care and Use Committee of the University of Minnesota.
Reproducibility Study
Five male Sprague-Dawley rats (body weight: 234723 g) were used for studying the reproducibility of two repeated CMRO 2 measurements in the same rat and experimental session. The rats were anesthetized with B2% (v/v) isoflurane in a mixture of O 2 and N 2 O gases (2:3) during surgery. After oral intubations, femoral artery and vein were catheterized for physiologic monitoring and/or blood sampling and chemical administration. Four of the five rats also underwent a surgical procedure for CBF measurements via a bolus injection of H 2
17
O directly into the brain through the internal carotid artery (see surgical details in Zhu et al, 2001) . After surgery, anesthesia was switched to a-chloralose by a bolus injection (40 mg/kg) and following continuous infusion (B20 mg/kg/h) of achloralose solution. Blood gases were sampled for monitoring physiologic conditions (pH = 7.3970.05, pCO 2 = 38 76 mm Hg, pO 2 = 148713 mm Hg, n = 5). The arterial blood pressure (110713 mm Hg) and heart rate (410725/ min) were also monitored during the experiment. The rectal temperature of the rats was maintained at B371C by using a heated circulating water blanket. ; 9 Â 9 Â 5 phase encodes; voxel size = 105 mL; radio frequency (RF) (hard) pulse length = 50 ms and spectral width = 15 kHz. A 17 Â 17 Â 9 matrix of free induced delays (FIDs) was generated from the original 9 Â 9 Â 5 phase encode data for each 3D
17 O MRS image. The FIDs were zero-filled, and a 100-Hz line broadening was used before fast Fourier transformation for signal to noise ratio (SNR) enhancement. 
Normothermia and Hypothermia Comparison Study
Five male Sprague-Dawley rats (body weight: 283725 g) were used for this study. The general surgical procedures were the same as described in the previous section. In addition, three of the five rats underwent a surgical preparation for the CBF measurement; and two of these three rats were also implanted a vascular 17 O RF coil, tuned at the 17 O Larmar frequency and wrapped around the intact carotid artery, allowing simultaneous measurement of arterial input function of H 2 17 O (C a (t)) and the brain H 2 17 O (C b (t)) signal with two 17 O RF coil configuration and two receiver channels (Zhang et al, 2003; Zhu et al, 2002) . The physiologic conditions of the rats, including arterial blood pressure, heart rate, inspired and expired gases were recorded throughout the experiment. Blood gases were sampled at different periods of the study. The rat brain temperatures under normothermic and hypothermic conditions were also monitored via a temperature sensor (PhysiTemp Instrument), which was inserted into the inner ear of the rats without poking through the membrane. After surgical preparation and animal settled inside the magnet, the anesthesia was switched to achloralose (initial bolus of 40 mg/kg followed by continuous infusion with infusion rate of B25 mg/kg/h). The normothermic and hypothermic conditions were controlled via a rectal temperature probe and a circulating water blanket with heated or refrigerated water.
Under stable normothermic condition (371C), a short 17 O 2 gas (72.1% or 89.9% enrichment) inhalation (B2 min) was performed on each rat, followed by a CBF measurement via bolus injection of H 2
17
O tracer (B0.05 mL, 50% enrichment) if it was applicable. After these measurements, the water pump for the circulating water blanket were switched to refrigerant mode and allowing the animal temperature to gradually decrease. When the body temperature of the rat reached the desired mild hypothermic (321C) condition, the water pump was switched back to the heating mode to maintain the temperature at 321C. This cooling process took approximately one and half hours. When the animal reached a stable hypothermic condition, second 17 O 2 inhalation experiment was performed on each rat. Therefore, the averaged time interval between the two CMRO 2 measurements for this study was longer than 2 h.
The parameters for acquiring 3D
O MRSI data were varied slightly among the rats in this group but were kept same for each rat. The acquisition time for each image was 10 to 12 secs with TR of 10 to 12 msecs and TE of 0.35 to 0.4 msecs. The voxel size was B50 to 100 mL with FOV of 2.2 Â 2.2 Â 1.8 cm 3 to 2.8 Â 2.8 Â 2.4 cm 3 and phase encodes of 9 Â 9 Â 5. A 50-ms RF hard pulse and 30 kHz spectral width were used for data acquisition, and a 17 Â 17 Â 9 matrix of FIDs was generated from the original 9 Â 9 Â 5 phase encode data for each 3D
O image. General data process and quantification procedures were the same as described above. 
where C a (t), C b (t) and C v (t) are the H 2 17 O concentrations in excess of the natural abundance H 2 17 O concentration level in the arterial blood, brain tissue and venous blood, respectively, as a function of 17 O 2 inhalation time (t, unit = min); a is the 17 O-enrichment fraction of inhaled 17 O 2 gas; l is the brain/blood partition coefficient. Two unit conversion factors, f 1 = 1.266 and f 2 = 1.05, are used to achieve consistency of units among all variables used in Eq. (1). The correction factor m was used to account for the fact that water is not completely freely diffusible across the brain-blood barrier. The constant n was a correction factor that accounts for another type of restriction on the permeability specifically for the metabolically generated H 2 17 O inside the mitochondria and it can be determined experimentally (Zhu et al, 2005 (Zhu et al, , 2002 . In general, C a (t) is linearly proportional to the inhalation time and can be expressed as C a (t) = At, in which A is a constant (Zhu et al, 2005 (Zhu et al, , 2002 . Solving the linear differential equation of Eq.
(1) led to the following equation: Therefore, the CMRO 2 value at each data point measured at different inhalation time can be calculated using the experimental data of CBF, A, n, C b (t), and other known constants (f 1 , f 2 , m, a, and l) according to Eq. (2). This quantification approach according to Eq. (2) is defined as a complete model, which accounts for all required parameters for precisely determining CMRO 2 (Zhang et al, 2004; Zhu et al, 2005 Zhu et al, , 2002 . However, this approach requires both invasive measurements (e.g., CBF, A and n measurements) and the noninvasive measurement of C b (t).
In contrast, the invasive measurements could be eliminated by using the simplified model based on the Taylor's and Polynomial Theorems (Zhang et al, 2004) . Briefly, the C b (t) time course can be expressed by a polynomial expansion
In this expansion, the first-order coefficient of a 1 can be used to calculate CMRO 2 using the following equation:
where a and f 1 are known constants. Thus, using the simplified model, only the experimental data of C b (t) measured by in vivo
O MRSI approach is needed and it can be fitted to the polynomial function given by Eq. (3) to calculate a 1 , and ultimately CMRO 2 according to Eq. (4). In this study, the polynomial function was approximated by a linear function for a short 17 O 2 inhalation time (Zhang et al, 2004) .
For the rats performed with multiple measurements of C a (t), C b (t), and CBF, both complete model and simplified model (linear fitting) were used for calculating and comparing CMRO 2 values at both normothermia and hypothermia conditions. The difference of CMRO 2 obtained at these two conditions reflects the change of CMRO 2 induced by temperature change. The CMRO 2 values calculated with completed model and/or simplified model from the same experimental data reflected the accuracy of the simplified model for quantifying CMRO 2 at normal brain temperature and mild hypothermia conditions.
Data and results are reported as means7standard deviation (s.d.).
Results
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The same data analysis method was applied for each of the five rats that underwent reproducibility study. The results are summarized in Table 1 . The mean7s.d. values of the first and second measured CMRO 2 values of these five rats were 2.2670.18 and 2.2070.14 mmol/g min, respectively; and the CMRO 2 ratio (1st/2nd) was 1.0370.05 (n = 5) with an average voxel number of 290738 (n = 5) per rat used for analysis. In four of the five rats, the differences between two CMRO 2 measurements were well within a 5% margin, and the difference was B10% for the other rat. Paired t-test show that PZ0.25 (n = 5), indicating that the first and second measured CMRO 2 values are statistically identical.
CMRO 2 Measurements at Normothermia and Hypothermia Conditions
Physiological parameters of the rats under normothermia (371C) and mild hypothermia (321C) conditions are summarized in Table 2 . While the blood gas data (pH, pCO 2 , and pO 2 ) were similar for the rats at two brain temperatures, the mean arterial blood pressure and the heart rate of the animal decreased significantly under the hypothermia condition. Figure 4 17 O 2 inhalation was significantly decreased under the hypothermia condition. The linear fittings to the two time courses of C b (t) from the same voxel indicate a dramatic CMRO 2 change (1.9 mmol/g/min at 371C versus 1.1 mmol/g/min at 321C).
We have demonstrated previously that under normal physiologic condition, CMRO 2 calculations based on the complete model, which requires invasive procedures and rigorous measurements of C b (t), C a (t), CBF, and n in the same animal, are in good agreement with the CMRO 2 calculation based on the simplified model which requires only one noninvasive measurement of C b (t) (Zhang et al, 2004; Zhu et al, 2005) . In this study, we performed similar measurements in the rat at normal temperature as well as under mild hypothermia to test whether the validity of the simplified model still holds in a wider physiologic range. Figure 5 shows the results of such a study in a representative rat brain in which all parameters involved in the CMRO 2 calculation according to the complete model were measured explicitly (Zhang et al, 2004) . The CMRO 2 values calculated with the complete model and simplified model for each individual 17 O MRSI voxels of the rat brain at 371C and 321C are presented in Figure 5A . The consistency and tight correlation (R = 0.97) between calculated CMRO 2 values using these two models are clearly evident for both normothermia and hypothermia conditions. The averaged CMRO 2 values of this rat at two different brain temperatures determined with both models are demonstrated in Figure 5B (complete model: CMRO 2 = 1.8470.29 mmol/g/min at 371C versus CMRO 2 = 1.1070.20 mmol/g/min at 321C; simplified model: CMRO 2 = 1.7770.23 mmol/g/min at 371C versus CMRO 2 = 1.1370.17 mmol/g/min at 321C). These CMRO 2 values obtained with two models Figure 2 ) in the rat brain at normal temperature (371C, full circles) and during mild hypothermia (321C, open circles) . The linear fitting of the data was used for calculating CMRO 2 values at two temperatures ( = 1.9 mmol/g/ min at 371C and 1.1 mmol/g/min at 321C).
are in excellent agreement at both temperatures without statistic difference. This result reveals that the simplified model based on linear fitting provides a good approximation for the true CMRO 2 values determined by the complete model, and this is valid not only under normal physiologic condition but also in the mild hypothermic rat brain. Using this simplified model, we could obtain 3D CMRO 2 maps of the rat brain in a completely noninvasive way. Figure 6 illustrates an example showing three representative slices of 3D CMRO 2 maps from a rat brain under normothermia ( Figure 6A ) and hypothermia ( Figure 6C ) conditions, as well as the corresponding anatomic images ( Figure 6B ). These images clearly displayed significant reduction of CMRO 2 across the entire brain induced by decreasing brain temperature several degrees. The reduction of the CMRO 2 during hypothermia is consistently observed in other four rats studied. Figure 7 summarizes the CMRO 2 values calculated with the simplified model in the rat brains at normothermia (371C, CMRO 2 = 1.8470.09 mmol/g/ min) and hypothermia (321C, CMRO 2 = 1.027 0.09 mmol/g/min) conditions (n = 5). The averaged voxel number used for calculating CMRO 2 for each rat was 249717 (371C) and 243716 (321C). High-field 17 O NMR approach for imaging CMRO 2 and its change Xiao-Hong Zhu et al Correlation Between CMRO 2 and CBF In addition to mapping CMRO 2 in the rat brain, the 17 O MRSI approach was used to determine absolute CBF in a subgroup of rats in both reproducibility study (CBF = 0.7270.07 mL/g/min (n = 4)) and normothermia/hypothermia comparison study (CBF = 0.5670.14 (371C) and 0.2770.13 (321C) mL/ g/min (n = 3)). Because the physiologic conditions of these rats covered a relatively wide range, it would be interesting to examine the relation between the CMRO 2 and CBF among these rats. Figure 8 summarizes the absolute values of CMRO 2 versus CBF in the a-chloralose-anesthetized rat brains. It shows a strong correlation between CBF and CMRO 2 in the rat brain at temperature ranging from 321C to 371C with a linear correlation coefficient of R = 0.97. This tight correlation was observed in the rat brains with the averaged CBF values ranging from 0.2 to 0.8 mL/g/min and averaged CMRO 2 values ranging from 1.0 to 2.5 mmol/g/min, which were experimentally determined in our study. In addition to our results, we also included in this figure the CBF versus CMRO 2 data from the literature reports of rat brains under similar a-chloralose anesthesia. These literature data, particularly CMRO 2 values, were obtained either directly (e.g. measure CMRO 2 with micro positron emission tomography (Yee et al, 2006) ) or indirectly (e.g. measure oxidative glucose consumption rate (CMR glc, ox ) with 13 C MRS (Hyder et al, 2000) or total glucose consumption rate (CMR glc, total ) with autoradiography (Cholet et al, 1997; Nakao et al, 2001) ) with various independent technical modalities and they agreed well with our results.
Discussion and conclusion
The superior 17 O NMR sensitivity available at ultrahigh field makes it possible for detecting and imaging small dynamic changes of metabolic H 2 17 O during a brief inhalation of 17 O 2 , and ultimately, for imaging CMRO 2 in three dimensions in the rat brain (Zhu et al, 2001 (Zhu et al, , 2002 . In this study, we further extended our investigation to address one important aspect of 17 O MRSI approach, that is, the reproducibility of CMRO 2 measurements.
Our results show that in the rat brain, especially for those voxels with high SNR as illustrated in Figure 2 , the reproducibility of two consecutive CMRO 2 measurements is extreamly high. When considering all the voxels located in the 17 O RF coil-sensitive region as shown in Figure 1 , the majority of the voxels present highly reproducible CMRO 2 values when voxel-by-voxel-based analysis was performed. This is evident from the ratio between two repeated CMRO 2 measurements, which is closed to unity in most of the voxels inside the rat brain. Because these repeated measurements were performed in the animal under stable physiologic condition without any perturbation, therefore, we conclude that the in vivo 17 O MRSI approach for repeated CMRO 2 measurements should provide consistent and reproducible outcomes. This capability is essential for studying the oxidative metabolism changes related to perturbations in physiology and brain function, in which at least two measurements are required under control and perturbation (or activation) conditions.
The feasibility of 3D 17 O MRS imaging for determining CMRO 2 changes because of physiologic perturbation was examined in the rat brain at normal brain temperature and under hypothermia condition. Our results show that in the same rat brain anesthetized with a-chloralose, a significant decrease of CMRO 2 was observed across the entire brain when the brain temperature decreased from 371C to 321C. The measured CMRO 2 ratio between normothermia and hypothermia conditions was 1.80 70.10 (n = 5). This value is similar to the CMRO 2 reduction observed in the thiopental-anesthetized rat brain when the brain temperature decreased from 381C to 341C (Nemoto et al, 1996) and/or calculated from depressed tricarboxylic acid cycle activity in the halothane-anesthetized rat brain when temperature decreased from 371C to 311C (Kaibara et al, 1999) . If assuming a linear relationship between CMRO 2 and temperature (Hagerdal et al, 1975) , we could estimate the Q 10 factor from our data resulting in Q 10 E2.2 for the rat brain anesthetized with achloralose. This Q 10 factor of CMRO 2 is in good agreement with the literature reports where global CMRO 2 measurements based on the Kety-Schmidt method were conducted (Hagerdal et al, 1975; Klementavicius et al, 1996; Michenfelder and Milde, 1991; Michenfelder and Theye, 1968; Nemoto et al, 1996) . The actual relation between CMRO 2 and brain temperature as well as their spatial dependence should be obtainable using the 3D 17 O MRS imaging approach; however, this topic is beyond the scope of this study.
In our previous work, we had demonstrated the feasibility to establish a completely noninvasive 17 O NMR approach for imaging CMRO 2 in the rat brain under normal physiology condition (Zhang et al, 2004) . In an effort of extending the applicability of this noninvasive CMRO 2 imaging approach to various physiologic conditions and/or in different species, we evaluated the validity of this method in the normothermic and hypothermic rat brains. Our results have clearly demonstrated that the CMRO 2 calculation based on the simplified model (i.e. linear fitting) and using only noninvasively determined brain metabolic H 2 17 O concentration could provide a close approximation of the true CMRO 2 values in the rat brain under both normothermic and mild hypothermic conditions. Therefore, the promising results from our previous as well as current studies conducted at ultrahigh field (i.e. 9.4T) provide crucial evidence supporting the notion that noninvasive 3D
17 O MRS imaging of CMRO 2 is not only feasible but also reliable, at least in the rat brain under a wide range of physiologic conditions.
There are only few methods that are able to determine absolute CBF and CMRO 2 values in a living brain without killing animal. Among them, the Kety-Schmidt method (Kety and Schmidt, 1948b) can provide global CMRO 2 and CBF information and has led to much of our knowledge about the circulation and metabolism in animal and human brain under a variety of physiologic or pathologic conditions. This method is considered as the most robust and reliable way to determine CMRO 2 and CBF values without information of their spatial distributions (see (Siesjo, 1978) and references therein). The positron emission tomography approach has been widely applied for imaging CMRO 2 and CBF in humans (Mintun et al, 1984; TerPogossian et al, 1970) (Pekar et al, 1991; Zhu et al, 2002 Zhu et al, , 2005 or in combination with other MR technique for CBF measurements (e.g. Arai et al, 1998; Pekar et al, 1995; Tailor et al, 2003) . At ultrahigh fields such as 9.4 T, we were able to obtain 3D CMRO 2 and CBF images of the rat brain with B50 to 105 mL vexel size as demonstrated in this study. Furthermore, by comparing the CMRO 2 and CBF values obtained from each rat brain at varied physiologic conditions, we were able to extrapolate the relation between CMRO 2 and CBF in the a-chloralose anesthetized rat brain. Our data indicate that CMRO 2 and CBF obey an approximate linear relationship (correlation coefficient: R = 0.97) within the physiologic conditions we studied. When comparing our results with the literature data of CMRO 2 and CBF in the a-chloralose anesthetized rat brains obtained with different technique modalities, we found that although they gave a range of CBF and CMRO 2 values in different studies with various anesthesia level and physiologic condition, these literature data points, however, are coincident with our data and, more importantly, they obey the same correlation relation between CMRO 2 and CBF (see Figure  8) . Our results also suggest that the reduction of CBF is comparable with that of CMRO 2 when the brain temperature of the animal decreases from 371C to 321C; that means, the coupling between the blood perfusion and oxidative metabolism is not significantly altered in the mild hypothermic rat brain under moderate anesthesia of a-chloralose.
In conclusion, the developed in vivo 17 O MRSI approach at ultrahigh fields is capable of repeated 3D CMRO 2 imaging within the same experimental session; it can provide reproducible CMRO 2 values in the rat brain under the same physiologic condition and can readily determine and distinguish the CMRO 2 changes induced by varying the physiologic states of the animal. The simplified analysis method for calculating CMRO 2 based solely on the noninvasively measured brain metabolic H 2 17 O concentration is valid under normal and mild hypothermia condition. Therefore, the same 17 O MRSI approach should be useful for studying other physiologic perturbations such as hypoxia and ischemia, as well as brain activation and brain diseases.
